Could CBD ease chronic pain? new trial seeks answers

NCT ID NCT03984565

Recruiting now Symptom relief Sponsor: Staci Gruber, Ph.D. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a high-CBD, low-THC sublingual product against a placebo in 25 adults with chronic pain conditions like arthritis or injury-related pain. Over 9 weeks, researchers will track pain levels, medication use, quality of life, and thinking skills to see if CBD offers real relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cannabidiol (CBD)
What this could lead to: If it works, this could point toward a non-addictive option for managing chronic pain and reducing reliance on conventional painkillers.
What could go wrong: This is a small, early-phase trial with only 25 participants. The results may not apply to everyone, and CBD may not outperform placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

McLean Hospital
RECRUITING

Belmont, Massachusetts, 02478, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.